HIDRADENITIS SUPPURATIVA
Clinical trials for HIDRADENITIS SUPPURATIVA explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising HS drug trial halted early – what it means for patients
Disease control TerminatedThis study tested a drug called izokibep for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. The trial aimed to see if izokibep could reduce skin abscesses and inflammation better than a placebo. However, the study was terminated early, so …
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE3 • Sponsor: ACELYRIN Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Promising HS drug trial halted early – what happened?
Disease control TerminatedThis study tested a new drug called SAR444656 in 70 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. The goal was to see if the drug could reduce abscesses and inflamed bumps better than a placebo over 16 weeks. However, the trial was termin…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New pill aims to calm stubborn skin flare-ups
Symptom relief TerminatedThis study tested an experimental oral drug called INF904 in people with moderate to severe chronic spontaneous urticaria (long-term hives) or hidradenitis suppurativa (a painful skin condition). Participants took the drug daily for 28 days, and researchers monitored safety and h…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: InflaRx GmbH • Aim: Symptom relief
Last updated May 26, 2026 11:42 UTC
-
Cream aims to calm painful skin boils in early-stage disease
Symptom relief TerminatedThis study tested a cream called ruxolitinib 1.5% on people with early-stage hidradenitis suppurativa, a skin condition that causes painful lumps. The goal was to see if the cream could reduce inflammation and improve symptoms after 16 weeks. The trial was stopped early and inclu…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated May 18, 2026 12:02 UTC
-
Scientists hunt for hidden genes behind painful skin condition
Knowledge-focused TerminatedThis study aimed to find a genetic link in people with Hidradenitis Suppurativa (HS), a chronic skin condition causing painful lumps. Researchers collected DNA from 97 participants, including affected individuals and their family members, to search for rare gene variants. The goa…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC